His-tag Antibody

What is a His-tag and how do His-tag antibodies work?

A His-tag (polyhistidine tag) consists of a series of six to nine histidine residues fused to either the carboxyl or amino terminus of a recombinant protein. The small size of the His-tag (approximately 1 kDa for a 6-His tag) makes it less likely to obstruct the target protein's structure or function compared to larger epitope tags, making it suitable for use under various experimental conditions including denaturing conditions .

His-tag antibodies are monoclonal or polyclonal antibodies specifically designed to recognize and bind to these histidine repeats, enabling researchers to detect and isolate His-tagged proteins without requiring a protein-specific antibody . The mechanism relies on the antibody's high affinity for the histidine sequence, allowing for specific detection across multiple experimental platforms.

What are the primary advantages of using His-tagged proteins in research?

His-tags offer several significant advantages in protein research:

• Minimal structural interference: Their small size (1 kDa) prevents interference with protein folding and function .

• Purification versatility: His-tagged proteins can be purified under both native and denaturing conditions, making them ideal for proteins expressed in inclusion bodies .

• Compatible with multiple detection methods: His-tags facilitate protein detection via Western blot, ELISA, immunofluorescence, flow cytometry, and immunoprecipitation .

• Cost-effective purification: His-tagged proteins can be purified using inexpensive and widely available nickel or cobalt resins .

• Stability: His-tags are more robust than larger protein tags due to their compact size .

What are the typical applications for His-tag antibodies?

His-tag antibodies are versatile tools validated for numerous applications:

• Western blot analysis: For detection of His-tagged proteins in cell lysates and purified fractions .

• Flow cytometry: Analysis of His-tagged proteins in transfected cells .

• Immunofluorescence: Visualization of His-tagged protein localization in cells .

• Immunohistochemistry and immunocytochemistry: Detection of His-tagged proteins in tissue and cell samples .

• ELISA: Quantification of His-tagged proteins in solution .

• Immunoprecipitation: Isolation of His-tagged proteins and their interaction partners .

• Functional assays: Assessment of binding interactions between His-tagged proteins and their targets .

How should I choose between N-terminal and C-terminal His-tagging for my protein?

The decision between N-terminal and C-terminal His-tagging depends on several factors related to your protein of interest:

• Protein structure: Examine structural data to determine which terminus is more exposed and less likely to interfere with functional domains.

• Signal peptides: For secreted proteins, avoid N-terminal tagging if the protein contains a signal peptide that would be cleaved during processing.

• Active sites: Position the tag away from catalytic or binding domains to minimize functional interference.

• Folding considerations: C-terminal tagging is often preferred as it allows the protein to fold properly during translation before the tag is synthesized.

• Terminal accessibility: Some proteins have buried N or C termini that might render the His-tag inaccessible to antibodies or purification matrices.

When possible, it can be valuable to create both N- and C-terminally tagged versions of your protein and compare their expression, solubility, and functionality to determine the optimal design .

What are the optimal buffer conditions for His-tag antibody detection and purification?

For optimal detection and purification of His-tagged proteins:

Binding/Wash Buffer (IMAC Purification):

• Near-neutral pH (7.0-7.5)

• Physiologic ionic strength

• Typically Tris-buffered saline (TBS) at pH 7.2

• Include 10-25 mM imidazole to prevent non-specific binding of endogenous histidine-rich proteins

• Compatible with high salt concentrations and certain denaturants (e.g., 8 M urea)

Elution Conditions:

• 250-500 mM imidazole in the same buffer used for binding/washing

• Alternatively, pH gradient (pH 4.5-5.0) can be used for elution

Important Considerations:

• Standard Ni-IMAC supports are incompatible with EDTA and reducing agents (DTT, TCEP) as these can strip the metal ions

• Specialized EDTA-compatible Ni-IMAC supports are available for proteins requiring EDTA for stability

• For Western blotting, standard transfer and blocking buffers are typically compatible with His-tag antibody detection

How can I optimize Western blot protocols specifically for His-tagged proteins?

To achieve optimal results when performing Western blots for His-tagged proteins:

• Sample Preparation:

  • Load appropriate amounts of E. coli lysate or cell lysate (recommended range: 0.5-10 μg/mL)

  • Use a reducing buffer with SDS for most applications to ensure complete denaturation

• Gel Selection:

  • 4-20% Tris-HCl polyacrylamide gels work well for a wide range of protein sizes

• Transfer Conditions:

  • PVDF membranes are recommended for optimal protein binding and signal

  • Standard transfer conditions (100V for 1 hour or 30V overnight) are typically sufficient

• Blocking:

  • 5% BSA in TBST is effective for reducing background

  • Block for at least 1 hour at room temperature

• Antibody Incubation:

  • Primary antibody dilution: 1:1000 to 1:2000 is typically effective

  • Incubate overnight at 4°C on a rocking platform

  • For HRP-conjugated His-tag antibodies, a single incubation step is sufficient

• Detection:

  • Use enhanced chemiluminescent substrates for high sensitivity

  • SuperSignal West Pico PLUS Chemiluminescent Substrate provides good results

• Controls:

  • Include a positive control (known His-tagged protein)

  • Include a negative control (non-tagged protein or untransfected cells)

How can I address non-specific binding issues with His-tag antibodies?

Non-specific binding is a common challenge when working with His-tag antibodies, as endogenous histidine-rich proteins can be detected. To minimize these issues:

• Optimize blocking conditions:

  • Increase BSA concentration (up to 5-10%)

  • Consider alternative blocking agents like casein or commercial blocking buffers

• Adjust antibody concentration and incubation time:

  • Reduce primary antibody concentration if non-specific binding persists

  • Shorter incubation times may reduce non-specific interactions

• Increase washing stringency:

  • Additional wash steps (5-6 washes)

  • Higher detergent concentration (0.1-0.3% Tween-20)

  • Include low concentrations of imidazole (5-10 mM) in wash buffers

• Be aware of endogenous proteins:

  • A ~60 kDa endogenous protein has been identified in HEK293T and HeLa cells that cross-reacts with some His-tag antibodies

  • Use proper controls (untransfected cells or non-tagged protein samples) to identify potential endogenous reactive proteins

• Consider antibody selection:

  • Different His-tag antibody clones may have different cross-reactivity profiles

  • Clone AD1.1.10 has been validated for specificity in multiple applications

What strategies exist for purifying His-tagged proteins under denaturing conditions?

Purifying His-tagged proteins under denaturing conditions is particularly valuable for insoluble proteins or inclusion bodies:

• Denaturation buffer options:

  • 8 M urea in TBS or PBS (pH 7.2-8.0)

  • 6 M guanidine hydrochloride

  • Both are compatible with Ni-IMAC purification

• Solubilization procedure:

  • Resuspend inclusion bodies in denaturing buffer

  • Sonicate or vortex thoroughly to ensure complete solubilization

  • Centrifuge at high speed to remove insoluble debris

  • Filter the supernatant before applying to the purification resin

• Purification considerations:

  • Use gravity-flow columns or batch purification rather than FPLC for highly denatured samples

  • Include 10-25 mM imidazole in binding/wash buffers to reduce non-specific binding

  • Elute with 250-500 mM imidazole in the same denaturing buffer

• On-column refolding option:

  • After binding the denatured protein, gradually reduce denaturant concentration in wash steps

  • Use a linear or step gradient from 8 M to 0 M urea

  • Add stabilizing agents (glycerol, arginine) in the later wash steps to prevent aggregation

• Post-purification handling:

  • Dialyze against refolding buffer gradually to remove denaturant

  • Consider adding stabilizers (0.5 M arginine, 10% glycerol) during refolding

  • Monitor protein aggregation during the refolding process

How can I differentiate between signals from my His-tagged protein and endogenous histidine-rich proteins?

Distinguishing between specific and non-specific signals is crucial for accurate data interpretation:

• Essential controls:

  • Untransfected/untreated cells or tissue as negative control

  • Cells expressing an unrelated His-tagged protein as positive control

  • Sequential dilutions of your sample to confirm signal intensity correlates with concentration

• Analytical approaches:

  • Compare the molecular weight of detected bands with the expected size of your His-tagged protein

  • Be aware that a ~60 kDa endogenous protein has been identified in HEK293T and HeLa cells that cross-reacts with some His-tag antibodies

  • Consider using multiple detection methods (e.g., both His-tag antibody and protein-specific antibody)

• Competitive binding assay:

  • Pre-incubate the antibody with excess free histidine peptide

  • Specific His-tag signals should be reduced while non-specific signals remain unchanged

• Alternative tag verification:

  • If possible, use a protein with dual tags (His-tag plus another tag)

  • Confirm signals using antibodies against both tags

• Knockout/knockdown verification:

  • If studying an endogenous protein with a His-tag, verify specificity through knockout or knockdown experiments

What are the considerations for using His-tag antibodies in complex samples like tissue lysates?

Working with complex samples presents unique challenges that require special considerations:

• Sample preparation optimization:

  • More stringent lysis conditions to ensure complete protein extraction

  • Additional centrifugation steps to remove particulates

  • Pre-clearing samples with protein A/G beads to reduce non-specific binding

• Background reduction strategies:

  • Include 10-25 mM imidazole in binding buffers to reduce non-specific interactions

  • Consider using detergents (0.1% Triton X-100 or NP-40) in wash buffers

  • Increase salt concentration (up to 500 mM NaCl) to reduce ionic interactions

• Detection method considerations:

  • Immunoprecipitation followed by Western blot may provide cleaner results than direct Western blot

  • For immunohistochemistry, more extensive blocking (BSA + normal serum) and additional washes are recommended

• Validation approaches:

  • Compare results across multiple detection methods

  • Use competitive binding assays with excess His-peptide

  • Include appropriate tissue from transgenic/knockout models as controls

• Antibody selection:

  • Monoclonal antibodies typically provide higher specificity in complex samples

  • Clone AD1.1.10 has been validated for specificity in multiple applications

How can His-tag antibodies be utilized in high-throughput protein interaction studies?

His-tag antibodies enable several sophisticated approaches for studying protein-protein interactions:

• Protein microarrays:

  • Immobilize His-tag antibodies on slides/chips

  • Capture His-tagged proteins of interest

  • Probe with fluorescently labeled interaction partners

  • Allows for simultaneous analysis of multiple interactions

• Pull-down assays with bead arrays:

  • Couple His-tag antibodies to distinctly colored or barcoded beads

  • Each bead population captures a different His-tagged protein

  • Incubate with complex samples and detect interacting partners

  • Flow cytometry analysis enables multiplex detection

• Automated immunoprecipitation platforms:

  • Standardized His-tag antibody-based pull-downs

  • Integration with liquid handling systems and mass spectrometry

  • Facilitates large-scale interactome studies

• Proximity-based detection methods:

  • Combine His-tag antibodies with split reporter systems

  • Use in bimolecular fluorescence complementation (BiFC) or proximity ligation assays (PLA)

  • Detect protein interactions in their native cellular context

• Real-time interaction monitoring:

  • His-tag antibodies immobilized on biosensor chips

  • Surface plasmon resonance (SPR) or biolayer interferometry (BLI) for kinetic analysis

  • High-throughput screening of interaction affinities

What advanced imaging applications can benefit from His-tag antibody technology?

His-tag antibodies can be leveraged for sophisticated imaging applications:

• Super-resolution microscopy:

  • Direct conjugation of His-tag antibodies with photoswitchable fluorophores

  • Enables STORM/PALM imaging of His-tagged proteins with nanometer precision

  • Particularly valuable for studying protein localization and dynamics

• Live-cell imaging approaches:

  • Cell-permeable His-tag antibody fragments

  • Conjugation with bright, photostable fluorophores

  • Track protein movement and interactions in living cells

• Multi-color imaging:

  • Combine His-tag antibodies with antibodies against endogenous proteins

  • Study co-localization and complex formation

  • Requires careful selection of compatible fluorophores to avoid spectral overlap

• Correlative light and electron microscopy (CLEM):

  • His-tag antibodies conjugated to both fluorescent tags and electron-dense markers

  • Visualize the same structures at different scales and resolutions

  • Bridge the resolution gap between light and electron microscopy

• Expansion microscopy compatibility:

  • Use His-tag antibodies in expanded samples

  • Benefit from physical sample expansion for improved resolution

  • Maintain the specificity advantage of His-tag detection

How can I optimize His-tag antibody protocols for challenging protein classes?

Certain protein classes present unique challenges for His-tag antibody applications:

• Membrane proteins:

  • Use mild detergents (DDM, CHAPS) for solubilization

  • Consider amphipols or nanodiscs for maintaining native structure

  • Position His-tags in predicted extramembrane domains

  • During purification, include detergent in all buffers to prevent aggregation

• Low-abundance proteins:

  • Implement tandem affinity purification strategies

  • Consider using dual-tagged constructs (His-tag plus another tag)

  • Optimize cell lysis to ensure complete extraction

  • Scale up starting material appropriately

• Heavily glycosylated proteins:

  • Position His-tags away from predicted glycosylation sites

  • Consider enzymatic deglycosylation prior to SDS-PAGE for accurate size determination

  • Test different His-tag antibody clones for optimal recognition

• Intrinsically disordered proteins:

  • Use chemical crosslinking before cell lysis to "freeze" interactions

  • Optimize fixation conditions for immunofluorescence

  • Include protease inhibitors to prevent degradation

  • Consider native purification conditions to maintain functional interactions

• Protein complexes:

  • Implement mild lysis and purification conditions to maintain complex integrity

  • Consider cross-linking strategies to stabilize transient interactions

  • Use gradient gels for SDS-PAGE to resolve all complex components

  • Consider blue native PAGE for analysis of intact complexes

How does the choice of metal ion affect the specificity and efficiency of His-tagged protein purification?

The choice of metal ion can significantly impact purification outcomes:

Considerations for metal ion selection:

• Nickel provides the best balance between binding capacity and specificity for 6xHis-tagged proteins

• Cobalt offers higher specificity but lower capacity, resulting in purer protein but lower yield

• Copper has the highest affinity but lowest specificity, useful for proteins that bind poorly to other metals

• Different metal ions require different elution conditions for optimal results

• Some proteins may show dramatically different behavior with different metal ions, warranting empirical testing

When should I choose His-tag antibodies over direct IMAC purification for protein detection?

Both approaches have distinct advantages in different research contexts:

Advantages of His-tag antibodies:

• Compatible with complex samples containing chelating agents (EDTA) or reducing agents (DTT)

• Can detect denatured proteins in fixed cells or tissues (immunohistochemistry)

• Allow for in situ detection of protein localization

• Can be used in multiplex detection formats with other antibodies

• Available with various conjugates (HRP, fluorophores) for different detection methods

Advantages of direct IMAC:

• Generally lower cost for large-scale purification

• Often higher capacity for protein purification

• Can be easily scaled up for preparative applications

• Fewer issues with batch-to-batch variation

• Often gentler elution conditions available

Decision factors:

• For protein localization studies, His-tag antibodies are required

• For large-scale protein production, IMAC is more cost-effective

• For samples containing EDTA or high concentrations of reducing agents, antibody-based detection may be preferable unless specialized EDTA-compatible resins are used

• When both approaches are feasible, empirical testing may be necessary to determine which provides better specificity and yield

How do His-tag antibodies compare with other tag detection systems for various applications?

Different tag systems have distinct characteristics that make them suitable for specific applications:

Application-specific recommendations:

• For structural studies:

  • His-tag is preferred due to its small size and minimal interference with protein structure

  • Site-specific cleavage sites can be incorporated for tag removal

• For protein-protein interaction studies:

  • His-tag or FLAG-tag offer minimal steric hindrance

  • GFP-tag allows for real-time visualization but may affect interactions

• For enhancing protein solubility:

  • MBP-tag or GST-tag are superior to His-tag

  • Consider dual tagging (e.g., His-MBP) for combined benefits

• For detection in complex samples:

  • FLAG-tag often provides higher specificity

  • His-tag may detect endogenous histidine-rich proteins

• For purification under denaturing conditions:

  • His-tag is clearly superior as it doesn't rely on tertiary structure

  • Most other tags require native conditions to function